Mineralocorticoid Action: Target Tissue Specificity Is Enzyme, Not Receptor, Mediated
The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
Mineralocorticoid receptors, both when in tissue extracts and when recombinant-derived, have equal affinity for the physiological mineralocorticoid aldosterone and for the glucocorticoids cortisol and corticosterone, which circulate at much higher concentrations than aldosterone. Such receptors are found in physiological mineralocorticoid target tissues (kidney, parotid, and colon) and in nontarget tissues such as hippocampus and heart. In mineralocorticoid target tissues the receptors are selective for aldosterone in vivo because of the presence of the enzyme 11 β-hydroxy-steroid dehydrogenase, which converts cortisol and corticosterone, but not aldosterone, to their 11-keto analogs. These analogs cannot bind to mineralocorticoid receptors.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In mineralocorticoid-responsive tissues such as the kidney, cortisol is enzymatically converted to cortisone, a metabolically inactive steroid (569).”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [569]
In the citing paper
“Thus, the type 2 enzyme inactivates the mineralocorticoid activity of cortisol in the kidney tubule (569), and inactivating mutations in the type 2 enzyme cause a syndrome of apparent mineralocorticoid excess (AME) (588).”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [569]
In the citing paper
“Thus, 11HSD2 prevents cortisol from overwhelming renal mineralocorticoid receptors (569), and in the placenta and other fetal tissues 11HSD2 (583, 584) also inactivates cortisol.”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [569]
In the citing paper
“The kidney has high levels of HSD11B2 activity which protects the mineralocorticoid receptor from activation by cortisol by inactivating it to cortisone (Edwards and Stewart, 1991, Funder et al., 1988).”
From Intracrine androgen biosynthesis, metabolism and action revisited (2018) · cites this paper as Funder et al., 1988
Citations
Cites
The Steroid and Thyroid Hormone Receptor Superfamily
Evans, R. M. (1988) · Science · doi:10.1126/science.3283939 · Cited by 7,439
Arriza, J. L., Weinberger, C., Cerelli, G., Glaser, T. M., Handelin, B. L., Housman, D. E., & Evans, R. M. (1987) · Science · doi:10.1126/science.3037703 · Cited by 1,946
Stewart, P., Valentino, R., Wallace, A. M., Burt, D., Shackleton, C. L., & Edwards, C. W. (1987) · The Lancet · doi:10.1016/s0140-6736(87)91014-2 · Cited by 803
Krozowski, Z. S., & Funder, J. W. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.19.6056 · Cited by 523
Self-citationThe Roles of Plasma Binding and Receptor Specificity in the Mineralocorticoid Action of Aldosterone1
FUNDER, J. W., FELDMAN, D., & EDELMAN, I. S. (1973) · Endocrinology · doi:10.1210/endo-92-4-994 · Cited by 232
Self-citationCharacterization of Rat Brain Aldosterone Receptors Reveals High Affinity for Corticosterone
BEAUMONT, K., & FANESTIL, D. D. (1983) · Endocrinology · doi:10.1210/endo-113-6-2043 · Cited by 193
Pearson Murphy, B. E. (1981) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(81)90226-0 · Cited by 178
Glucocorticoid Receptors in Rat Kidney: The Rinding of Tritiated-Dexamethasone1
FUNDER, J. W., FELDMAN, D., & EDELMAN, I. S. (1973) · Endocrinology · doi:10.1210/endo-92-4-1005 · Cited by 173
Self-citationAFFINITY OF LIQUORICE DERIVATIVES FOR MINERALOCORTICOID AND GLUCOCORTICOID RECEPTORS
ARMANINI, D., KARBOWIAK, I., & FUNDER, J. W. (1983) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1983.tb00038.x · Cited by 157
Self-citationGlucocorticoid and mineralocorticoid receptors for aldosterone
Rousseau, G. G., Baxter, J. D., Funder, J. W., Edelman, I. S., & Tomkins, G. M. (1972) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(72)90053-2 · Cited by 151
Self-citation
Research works printed but not linked: 4
- Krozowski, Z. S., Proceedings of the National Academy of Sciences of the United States of America 80: 6056 (1983).
- SHEPPARD, K, MINERALOCORTICOID SPECIFICITY OF RENAL TYPE-I RECEPTORS - INVIVO BINDING-STUDIES, AMERICAN JOURNAL OF PHYSIOLOGY 252: E224 (1987).
- SHEPPARD, K, TYPE-I RECEPTORS IN PAROTID, COLON, AND PITUITARY ARE ALDOSTERONE SELECTIVE INVIVO, AMERICAN JOURNAL OF PHYSIOLOGY 253: E467 (1987).
- STEWART, P.M., CORTICOSTEROIDS PEPT 39: 163 (1987).
Cited by
Brain corticosteroid receptor balance in health and disease
de Kloet, E. R., Vreugdenhil, E., Oitzl, M. S., & Joëls, M. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.3.0331 · Cited by 2,614
Brain corticosteroid receptor balance in health and disease
de Kloet, E. R. (1998) · Endocrine Reviews · doi:10.1210/er.19.3.269 · Cited by 2,614
The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders
Miller, W. L., & Auchus, R. J. (2011) · Endocrine Reviews · doi:10.1210/er.2010-0013 · Cited by 2,458
Molecular Mechanisms of Human Hypertension
Lifton, R. P., Gharavi, A. G., & Geller, D. S. (2001) · Cell · doi:10.1016/s0092-8674(01)00241-0 · Cited by 1,686
Reproduction and Resistance to Stress: When and How
Wingfield, J. C., & Sapolsky, R. M. (2003) · Journal of Neuroendocrinology · doi:10.1046/j.1365-2826.2003.01033.x · Cited by 1,141
Cole, T. J., Blendy, J. A., Monaghan, A. P., Krieglstein, K., Schmid, W., Aguzzi, A., Fantuzzi, G., Hummler, E., Unsicker, K., & Schütz, G. (1995) · Genes & Development · doi:10.1101/gad.9.13.1608 · Cited by 946
Molecular Determinants of Glucocorticoid Receptor Function and Tissue Sensitivity to Glucocorticoids
BAMBERGER, C. M., SCHULTE, H. M., & CHROUSOS, G. P. (1996) · Endocrine Reviews · doi:10.1210/edrv-17-3-245 · Cited by 889
“In these cells, the enzyme 11/3-hydroxysteroid dehydrogenase (11/3-HSD) metabolizes the incoming cortisol and thereby renders the cells specifically mineralocorticoid-responsive (91-93).”
Background11β-hydroxysteroid dehydrogenases: Intracellular gate-keepers of tissue glucocorticoid action
Chapman, K., Holmes, M., & Seckl, J. (2013) · Physiological Reviews · doi:10.1152/physrev.00020.2012 · Cited by 887
“The solution was provided in the late 1980s by the Edinburgh group (181, 672), as well as Funder and colleagues in Melbourne (210), who recognized that selectivity of MR in the kidney in vivo was not due to any intrinsic specificity for aldosterone but to the activity of 11 -HSD.”
MethodKotelevtsev, Y., Holmes, M. C., Burchell, A., Houston, P. M., Schmoll, D., Jamieson, P., Best, R., Brown, R., Edwards, C. R. W., Seckl, J. R., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.26.14924 · Cited by 858
McEwen, B. S., Biron, C. A., Brunson, K. W., Bulloch, K., Chambers, W. H., Dhabhar, F. S., Goldfarb, R. H., Kitson, R. P., Miller, A. H., Spencer, R. L., et al. (1997) · Brain Research Reviews · doi:10.1016/s0165-0173(96)00012-4 · Cited by 837
Steroid Receptor Family: Structure and Functions
CARSON-JURICA, M. A., SCHRADER, W. T., & O'MALLEY, B. W. (1990) · Endocrine Reviews · doi:10.1210/edrv-11-2-201 · Cited by 811
Stress, Glucocorticoids, and Damage to the Nervous System: The Current State of Confusion
Sapolsky, R. M. (1996) · Stress · doi:10.3109/10253899609001092 · Cited by 738
Epithelial sodium channel regulated by aldosterone-induced protein sgk
Chen, S.-Y., Bhargava, A., Mastroberardino, L., Meijer, O. C., Wang, J., Buse, P., Firestone, G. L., Verrey, F., & Pearce, D. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.5.2514 · Cited by 734
Glucocorticoids and insulin resistance: old hormones, new targets
ANDREWS, R. C., & WALKER, B. R. (1999) · Clinical Science · doi:10.1042/cs0960513 · Cited by 731
11β-Hydroxysteroid Dehydrogenase
Stewart, P. M., & Krozowski, Z. S. (1997) · Vitamins & Hormones · doi:10.1016/s0083-6729(08)60646-9 · Cited by 718
Seckl, J. R., & Walker, B. R. (2001) · Endocrinology · doi:10.1210/endo.142.4.8114 · Cited by 714
Cloning and tissue distribution of the human 1 lβ-hydroxysteroid dehydrogenase type 2 enzyme
Albiston, A. L., Obeyesekere, V. R., Smith, R. E., & Krozowski, Z. S. (1994) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(94)90176-7 · Cited by 712
Self-citationLinks Between Dietary Salt Intake, Renal Salt Handling, Blood Pressure, and Cardiovascular Diseases
Meneton, P., Jeunemaitre, X., de Wardener, H. E., & Macgregor, G. A. (2005) · Physiological Reviews · doi:10.1152/physrev.00056.2003 · Cited by 703
“Inactivating mutations of the 11 -HSD2 are responsible of the apparent mineralocorticoid excess, a rare recessive but severe form of hypertension (109, 254, 349).”
BackgroundEndocrine Regulation of Human Fetal Growth: The Role of the Mother, Placenta, and Fetus
Murphy, V. E., Smith, R., Giles, W. B., & Clifton, V. L. (2006) · Endocrine Reviews · doi:10.1210/er.2005-0011 · Cited by 671
Self-citationSPECIFIC, NONGENOMIC ACTIONS OF STEROID HORMONES
Wehling, M. (1997) · Annual Review of Physiology · doi:10.1146/annurev.physiol.59.1.365 · Cited by 661
Molecular Genetics of Human Blood Pressure Variation
Lifton, R. P. (1996) · Science · doi:10.1126/science.272.5262.676 · Cited by 629
Human hypertension caused by mutations in the kidney isozyme of 11β–hydroxysteroid dehydrogenase
Mune, T., Rogerson, F. M., Nikkilä, H., Agarwal, A. K., & White, P. C. (1995) · Nature Genetics · doi:10.1038/ng0895-394 · Cited by 619
Regulation of the hypothalamic corticotropin-releasing hormone neurosecretory system
Whitnall, M. H. (1993) · Progress in Neurobiology · doi:10.1016/0301-0082(93)90035-q · Cited by 582
11β-Hydroxysteroid Dehydrogenase and the Syndrome of Apparent Mineralocorticoid Excess*
White, P. C., Mune, T., & Agarwal, A. K. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.1.0288 · Cited by 517
Sodium-Potassium-Adenosinetriphosphatase-Dependent Sodium Transport in the Kidney: Hormonal Control
Féraille, E., & Doucet, A. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.1.345 · Cited by 500
Morimoto, M., Morita, N., Ozawa, H., Yokoyama, K., & Kawata, M. (1996) · Neuroscience Research · doi:10.1016/s0168-0102(96)01105-4 · Cited by 480
Cloning and expression of rat cDNA encoding corticosteroid 11β-dehydrogenase
Agarwal, A. K., Monder, C., Eckstein, B., & White, P. C. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)47248-7 · Cited by 455
Contribution of aldosterone to cardiovascular and renal inflammation and fibrosis
Brown, N. J. (2013) · Nature Reviews Nephrology · doi:10.1038/nrneph.2013.110 · Cited by 451
Pearce, D., & Yamamoto, K. R. (1993) · Science · doi:10.1126/science.8382376 · Cited by 451
Myocardial Production of Aldosterone and Corticosterone in the Rat
Silvestre, J.-S., Robert, V., Heymes, C., Aupetit-Faisant, B., Mouas, C., Moalic, J.-M., Swynghedauw, B., & Delcayre, C. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.9.4883 · Cited by 446
Morton, N. M., Holmes, M. C., Fiévet, C., Staels, B., Tailleux, A., Mullins, J. J., & Seckl, J. R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103676200 · Cited by 439
Molecular Endocrinology of Hydroxysteroid Dehydrogenases*
Penning, T. M. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.3.0302 · Cited by 438
Adrenocortical Responses to Stress and Their Modulation in Free‐Living Vertebrates
Wingfield, J. C., & Romero, L. M. (2001) · Comprehensive Physiology · doi:10.1002/cphy.cp070411 · Cited by 438
Mineralocorticoids, hypertension, and cardiac fibrosis.
Young, M., Fullerton, M., Dilley, R., & Funder, J. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117269 · Cited by 437
Self-citationThe renin-angiotensin-aldosterone system and its suppression
Ames, M. K., Atkins, C. E., & Pitt, B. (2019) · Journal of Veterinary Internal Medicine · doi:10.1111/jvim.15454 · Cited by 433
Chronic Stress-induced Hippocampal Vulnerability: The Glucocorticoid Vulnerability Hypothesis
Conrad, C. D. (2008) · Reviews in the Neurosciences · doi:10.1515/revneuro.2008.19.6.395 · Cited by 425
The glucocorticoid responses are shaped by molecular chaperones
Grad, I., & Picard, D. (2007) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2007.05.018 · Cited by 423
Mineralocorticoid receptor knockout mice: Pathophysiology of Na + metabolism
Berger, S., Bleich, M., Schmid, W., Cole, T. J., Peters, J., Watanabe, H., Kriz, W., Warth, R., Greger, R., & Schütz, G. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.16.9424 · Cited by 418
MINIREVIEW: Interactions Among a Subfamily of Nuclear Hormone Receptors: The Regulatory Zipper Model
Forman, B. M., & Samuels, H. H. (1990) · Molecular Endocrinology · doi:10.1210/mend-4-9-1293 · Cited by 414
Corticosteroid effects in the brain: U-shape it
Joëls, M. (2006) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2006.03.007 · Cited by 411
Goraya, N., Simoni, J., Jo, C.-H., & Wesson, D. E. (2013) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.02430312 · Cited by 410
A users guide to HPA axis research
Spencer, R. L., & Deak, T. (2017) · Physiology & Behavior · doi:10.1016/j.physbeh.2016.11.014 · Cited by 405
Control of neuronal excitability by corticosteroid hormones
Joëls, M., & de Kloet, E. R. (1992) · Trends in Neurosciences · doi:10.1016/0166-2236(92)90345-9 · Cited by 400
Joëls, M., & Ronald de Kloet, E. (1994) · Progress in Neurobiology · doi:10.1016/0301-0082(94)90014-0 · Cited by 392
“In the presence of this blocker, corticosterone was not metabolized and binds to MRs like aldosterone {Funder et al., 1988; Edwards et al., 1988).”
Charting of Type II glucocorticoid receptor-like immunoreactivity in the rat central nervous system
Ahima, R. S., & Harlan, R. E. (1990) · Neuroscience · doi:10.1016/0306-4522(90)90244-x · Cited by 360
Jaffe, I. Z., & Mendelsohn, M. E. (2005) · Circulation Research · doi:10.1161/01.res.0000159937.05502.d1 · Cited by 358
The new biology of aldosterone
Connell, J. M. C., & Davies, E. (2005) · Journal of Endocrinology · doi:10.1677/joe.1.06017 · Cited by 356
“The key explanation was provided by seminal studies which characterized the 11 -HSD type 2 (11 -HSD2) enzyme complex, which colocalizes with MRs in target epithelial tissues and is also found in placenta and vascular tissue (Funder et al. 1988, Stewart et al. 1988).”
BackgroundImpaired renal Na+ retention in the sgk1-knockout mouse
Wulff, P., Vallon, V., Huang, D. Y., Völkl, H., Yu, F., Richter, K., Jansen, M., Schlünz, M., Klingel, K., Loffing, J., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15696 · Cited by 353
“Low dietary Na+ intake (12, 13) or exogenous application of aldosterone (14) increases the apical abundance of ENaC in the renal collecting system, the renal target for mineralocorticoid action (15).”
BackgroundAldosterone Production Is Activated in Failing Ventricle in Humans
Mizuno, Y., Yoshimura, M., Yasue, H., Sakamoto, T., Ogawa, H., Kugiyama, K., Harada, E., Nakayama, M., Nakamura, S., Ito, T., et al. (2001) · Circulation · doi:10.1161/01.cir.103.1.72 · Cited by 345
Herman, J. P., Patel, P. D., Akil, H., & Watson, S. J. (1989) · Molecular Endocrinology · doi:10.1210/mend-3-11-1886 · Cited by 328
“Unlike the kidney, hippocampus has no detectable levels of the B-inactivating enzyme 11/8-hydroxysteroid dehydrogenase, thus rendering circulating B predominant over mineralocorticoids in its ability to bind type 1 receptors (26).”
BackgroundAldosterone and end-organ damage
Brown, N. J. (2005) · Current Opinion in Nephrology and Hypertension · doi:10.1097/01.mnh.0000165889.60254.98 · Cited by 320
The Mineralocorticoid Receptor: Insights into its Molecular and (Patho)Physiological Biology
Viengchareun, S., Le Menuet, D., Martinerie, L., Munier, M., Tallec, L. P.-L., & Lombès, M. (2007) · Nuclear Receptor Signaling · doi:10.1621/nrs.05012 · Cited by 316
“…of MR was always associated with expression of the 11-beta hydroxysteroid dehydrogenase 2 (11-β HSD2), the enzyme that allows aldosterone to selectively activate MR, by converting glucocorticoid hormones to their 11-keto analogs, unable to bind MR [Edwards et al., 1988; Funder et al., 1988].”
Lindsay, R. S., Lindsay, R. M., Edwards, C. R. W., & Seckl, J. R. (1996) · Hypertension · doi:10.1161/01.hyp.27.6.1200 · Cited by 310
Immunohistochemical and biochemical evidence for a cardiovascular mineralocorticoid receptor.
Lombès, M., Oblin, M. E., Gasc, J. M., Baulieu, E. E., Farman, N., & Bonvalet, J. P. (1992) · Circulation Research · doi:10.1161/01.res.71.3.503 · Cited by 309
MONDER, C., STEWART, P. M., LAKSHMI, V., VALENTINO, R., BURT, D., & EDWARDS, C. R. W. (1989) · Endocrinology · doi:10.1210/endo-125-2-1046 · Cited by 305
Jamieson, P. M., Chapman, K. E., Edwards, C. R. W., & Seckl, J. R. (1995) · Endocrinology · doi:10.1210/en.136.11.4754 · Cited by 301
Critical Illness-Related Corticosteroid Insufficiency
Marik, P. E. (2009) · Chest · doi:10.1378/chest.08-1149 · Cited by 299
Seckl, J. R. (1997) · Steroids · doi:10.1016/s0039-128x(96)00165-1 · Cited by 298
Licorice-Induced Hypermineralocorticoidism
Farese, R. V., Biglieri, E. G., Shackleton, C. H. L., Irony, I., & Gomez-Fontes, R. (1991) · New England Journal of Medicine · doi:10.1056/nejm199110243251706 · Cited by 295
Lombès, M., Alfaidy, N., Eugene, E., Lessana, A., Farman, N., & Bonvalet, J.-P. (1995) · Circulation · doi:10.1161/01.cir.92.2.175 · Cited by 292
Güder, G., Bauersachs, J., Frantz, S., Weismann, D., Allolio, B., Ertl, G., Angermann, C. E., & Störk, S. (2007) · Circulation · doi:10.1161/circulationaha.106.653964 · Cited by 292
BENS, M., VALLET, V., CLUZEAUD, F. C., PASCUAL-LETALLEC, L., KAHN, A., RAFESTIN-OBLIN, M. E., ROSSIER, B. C., & VANDEWALLE, A. (1999) · Journal of the American Society of Nephrology · doi:10.1681/asn.v105923 · Cited by 287
Hypertension and the cortisol-cortisone shuttle
Quinkler, M., & Stewart, P. M. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030138 · Cited by 286
Impaired renal Na+ retention in the sgk1-knockout mouse
Wulff, P., Vallon, V., Huang, D. Y., Völkl, H., Yu, F., Richter, K., Jansen, M., Schlünz, M., Klingel, K., Loffing, J., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215696 · Cited by 283
Walker, B. R. (1995) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.80.11.3155 · Cited by 277
Central regulation of sodium appetite
Geerling, J. C., & Loewy, A. D. (2008) · Experimental Physiology · doi:10.1113/expphysiol.2007.039891 · Cited by 274
“Only cells that express both MR and HSD2 are sensitized to the relatively low levels of circulating aldosterone (Funder et al. 1988; Naray-Fejes-Toth et al. 1998).”
BackgroundAldosterone in the development and progression of renal injury
Hollenberg, N. K. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00701.x · Cited by 273
Rossier, B. C., Baker, M. E., & Studer, R. A. (2015) · Physiological Reviews · doi:10.1152/physrev.00011.2014 · Cited by 269
“Part of this apparent paradox is explained by the coexpression of 11 HSD2 (HSD11B2), a very active enzyme that converts cortisol (active) into cortisone (inactive) due to its low affinity for the MR and GR (83, 110).”
BackgroundMultiple aspects of mineralocorticoid selectivity
Farman, N., & Rafestin-Oblin, M.-E. (2001) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.2001.280.2.f181 · Cited by 268
“Twelve years ago (29, 47), it was demonstrated that an enzyme, 11b-hydroxysteroid dehydrogenase (11b-HSD), plays a critical role in preventing major glucocorticoid access to the cells.”
BackgroundGreenwood, A. K., Butler, P. C., White, R. B., DeMarco, U., Pearce, D., & Fernald, R. D. (2003) · Endocrinology · doi:10.1210/en.2003-0566 · Cited by 266
Andrews, R. C., Rooyackers, O., & Walker, B. R. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021194 · Cited by 266
Neural circuits underlying thirst and fluid homeostasis
Zimmerman, C. A., Leib, D. E., & Knight, Z. A. (2017) · Nature Reviews Neuroscience · doi:10.1038/nrn.2017.71 · Cited by 263
Alberts, P., Nilsson, C., Selén, G., Engblom, L. O. M., Edling, N. H. M., Norling, S., Klingström, G., Larsson, C., Forsgren, M., Ashkzari, M., et al. (2003) · Endocrinology · doi:10.1210/en.2003-0344 · Cited by 263
Induction of Cardiac Fibrosis by Aldosterone
Lijnen, P., & Petrov, V. (2000) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.2000.1129 · Cited by 263
Transgenic Model of Aldosterone-Driven Cardiac Hypertrophy and Heart Failure
Qin, W., Rudolph, A. E., Bond, B. R., Rocha, R., Blomme, E. A. G., Goellner, J. J., Funder, J. W., & McMahon, E. G. (2003) · Circulation Research · doi:10.1161/01.res.0000080521.15238.e5 · Cited by 262
Self-citationEvidence for two distinct functional glucocorticoid receptors in teleost fish
Bury, N., Sturm, A., Le Rouzic, P., Lethimonier, C., Ducouret, B., Guiguen, Y., Robinson-Rechavi, M., Laudet, V, Rafestin-Oblin, M., & Prunet, P. (2003) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0310141 · Cited by 262
“This is clearly different from the situation in mammals where the MR binds cortisol (or corticosterone) and aldosterone with equal affinity (Funder et al. 1988).”
BackgroundMihailidou, A. S., Loan Le, T. Y., Mardini, M., & Funder, J. W. (2009) · Hypertension · doi:10.1161/hypertensionaha.109.136242 · Cited by 262
“In separate studies, we added the low molecular weight and highly permeable superoxide dismutase mimetic Tempol (4-hydroxy2,2,6,6-tetramethylpiperidine-N-oxyl; 100 mol/L) to the perfusate to scavenge the formation of reactive oxygen species on reperfusion.”
InfluentialSelf-citationThe role of corticosteroids in the regulation of vascular tone
Ullian, M. (1999) · Cardiovascular Research · doi:10.1016/s0008-6363(98)00230-2 · Cited by 260
P., A., L., E., N., E., M., F., G., K., C., L., Y., R.-N., B., Ö., & L., A. (2002) · Diabetologia · doi:10.1007/s00125-002-0959-6 · Cited by 259
Aldosterone and Vascular Inflammation
Brown, N. J. (2008) · Hypertension · doi:10.1161/hypertensionaha.107.095489 · Cited by 256
Bujalska, I. J., Kumar, S., Hewison, M., & Stewart, P. M. (1999) · Endocrinology · doi:10.1210/endo.140.7.6868 · Cited by 254
Adipocyte-Specific Glucocorticoid Inactivation Protects Against Diet-Induced Obesity
Kershaw, E. E., Morton, N. M., Dhillon, H., Ramage, L., Seckl, J. R., & Flier, J. S. (2005) · Diabetes · doi:10.2337/diabetes.54.4.1023 · Cited by 253
“11 HSD2 is a highaffinity NAD-dependent dehydrogenase expressed primarily in mineralocorticoid target tissues, such as kidney, where it potently decreases local GC action, thus ensuring that only the nonsubstrate aldosterone can access intrinsically nonselective mineralocorticoid receptors (6,7).”
BackgroundKrozowski, Z., MaGuire, J. A., Stein-Oakley, A. N., Dowling, J., Smith, R. E., & Andrews, R. K. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.7.7608280 · Cited by 252
Self-citationSturm, A., Bury, N., Dengreville, L., Fagart, J., Flouriot, G., Rafestin-Oblin, M. E., & Prunet, P. (2005) · Endocrinology · doi:10.1210/en.2004-0128 · Cited by 247
Licorice abuse: time to send a warning message
Omar, H. R., Komarova, I., El-Ghonemi, M., Fathy, A., Rashad, R., Abdelmalak, H. D., Yerramadha, M. R., Ali, Y., Helal, E., & Camporesi, E. M. (2012) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018812454322 · Cited by 246
“This effect is physiologically important because cortisol binds as avidly as aldosterone to the mineralocorticoid receptor (MR) [Funder et al. 1988].”
BackgroundAgarwal, A. K., Mune, T., Monder, C., & White, P. C. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47142-6 · Cited by 246
11β-Hydroxysteroid dehydrogenases and the brain: From zero to hero, a decade of progress
Wyrwoll, C. S., Holmes, M. C., & Seckl, J. R. (2011) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2010.12.001 · Cited by 244
“Funder and colleagues in Melbourne [72], recognised that selectivity of MR in the kidney in vivo was not due to any intrinsic specificity for aldosterone over glucocorticoids but to the activity of 11b-HSD.”
Isnard Bagnis, C., Deray, G., Baumelou, A., Le Quintrec, M., & Vanherweghem, J. L. (2004) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2004.02.009 · Cited by 244
A Nuclear Receptor Atlas: Macrophage Activation
Barish, G. D., Downes, M., Alaynick, W. A., Yu, R. T., Ocampo, C. B., Bookout, A. L., Mangelsdorf, D. J., & Evans, R. M. (2005) · Molecular Endocrinology · doi:10.1210/me.2004-0529 · Cited by 243
Stewart, P. M., Gupta, A., Sheppard, M. C., Whorwood, C. B., Howie, A. J., Milford, D. V., & Krozowski, Z. S. (1996) · The Lancet · doi:10.1016/s0140-6736(96)90211-1 · Cited by 241
Glucocorticoids and 11beta-Hydroxysteroid Dehydrogenase in Adipose Tissue
Seckl, J. R. (2004) · Recent Progress in Hormone Research · doi:10.1210/rp.59.1.359 · Cited by 239
“11 -HSD2 functions predominantly to exclude glucocorticoids from intrinsically nonselective MR in vivo (Edwards et al., 1988; Funder et al., 1988).”
Ahima, R., Krozowski, Z., & Harlan, R. E. (1991) · Journal of Comparative Neurology · doi:10.1002/cne.903130312 · Cited by 232
Mineralocorticoid Receptors: Distribution and Activation
Funder, J. W. (2005) · Heart Failure Reviews · doi:10.1007/s10741-005-2344-2 · Cited by 229
“On the basis of these clinical studies it was established that the physiologic role of 11β hydroxysteroid dehydrogenase in the kidney was to convert cortisol to receptor-inactive cortisone (corticosterone to 11-dehydrocorticosterone in rats and mice) thus protecting mineralocorticoid receptors from occupancy and activ…”
Self-citationLangley-Evans, S. C., Gardner, D. S., & Jackson, A. A. (1996) · The Journal of Nutrition · doi:10.1093/jn/126.6.1578 · Cited by 229
The brain mineralocorticoid receptor: greedy for ligand, mysterious in function
Reul, J. M. H. M., Gesing, A., Droste, S., Stec, I. S. M., Weber, A., Bachmann, C., Bilang-Bleuel, A., Holsboer, F., & Linthorst, A. C. E. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00677-4 · Cited by 227
“…11b-hydroxyŽsteroid dehydrogenase which physiologically metabolizes natural glucocorticoids, thereby allowing the AselectiveB access of mineralocorticoid hormones to mineralocorticoid .receptors in this tissue is irrelevant as dexamethasone is Žnot a substrate for this enzyme Funder et al., 1988; .”
BackgroundDisorders of Aldosterone Biosynthesis and Action
Epstein, F. H., & White, P. C. (1994) · New England Journal of Medicine · doi:10.1056/nejm199407283310408 · Cited by 225
MOISAN, M.-P., SECKL, J. R., & EDWARDS, C. R. W. (1990) · Endocrinology · doi:10.1210/endo-127-3-1450 · Cited by 221
Keller, H. (1995) · Molecular Endocrinology · doi:10.1210/me.9.7.794 · Cited by 220
Paradoxical effects of adrenal steroids on the brain: Protection versus degeneration
McEwen, B. S., Angulo, J., Cameron, H., Chao, H. M., Daniels, D., Gannon, M. N., Gould, E., Mendelson, S., Sakai, R., Spencer, R., et al. (1992) · Biological Psychiatry · doi:10.1016/0006-3223(92)90204-d · Cited by 219
Bledsoe, R. K., Madauss, K. P., Holt, J. A., Apolito, C. J., Lambert, M. H., Pearce, K. H., Stanley, T. B., Stewart, E. L., Trump, R. P., Willson, T. M., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m504098200 · Cited by 218
Metadata
- Authors
- Funder, J. W., Pearce, P. T., Smith, R., & Smith, A. I.
- Affiliations
- Medical Research Centre, Prince Henry's Hospital, Melbourne, Australia 3004.
- Venue
- Science
- Published
- 1988-10-28
- Volume
- 242
- Issue
- 4878
- Pages
- 583-585
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2148114970
- Semantic Scholar
- ae47dabb539e84fc85ea0bfd3f1a669037f37264
- Cited by
- 1,628
- References
- 19
- Citations by year
- 2026: 15 · 2025: 7 · 2024: 21 · 2023: 21 · 2022: 16 · 2021: 25 · 2020: 25 · 2019: 32 · 2018: 32 · 2017: 33 · 2016: 26 · 2015: 30 · 2014: 37 · 2013: 44 · 2012: 56
- FWCI
- 30.19
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- mineralocorticoid receptor, aldosterone, glucocorticoids, cortisol, corticosterone, 11β-hydroxysteroid dehydrogenase, 11-keto steroids, kidney, parotid gland, colon, hippocampus, heart
- MeSH terms
- Adrenalectomy, Aldosterone, Animals, Carbenoxolone, Colon, Corticosterone, Heart, Hippocampus, Hydrocortisone, Hydroxysteroid Dehydrogenases, Kidney, Parotid Gland, Receptors, Steroid, Receptors, Mineralocorticoid, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.